Abatacept Post-marketing Clinical Study in Japan

PHASE4CompletedINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

April 11, 2013

Primary Completion Date

December 26, 2016

Study Completion Date

December 26, 2016

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Abatacept

DRUG

Placebo matching with Abatacept

DRUG

Methotrexate

Trial Locations (74)

296-8602

Local Institution, Kamogawa

501-6061

Local Institution, Kasamatsu-town

675-8611

Local Institution, Kakogawa

245-8575

Local Institution, Yokohama

710-8602

Local Institution, Kurashiki

598-0048

Local Institution, Izumisano

426-8677

Local Institution, Fujieda

930-8550

Local Institution, Toyama

750-8520

Local Institution, Shimonoseki

289-2511

Local Institution, Asahi

183-8524

Local Institution, Fuchū

810-8563

Local institution, Fukuoka

813-0017

Local Institution, Fukuoka

274-0053

Local institution, Funabashi

040-8611

Local Institution, Hakodate

734-8551

Local Institution, Hiroshima

316-0015

Local Institution, Hitachi

078-8243

Local institution, Hokkaido

820-8505

Local Institution, Iizuka

890-0067

Local Institution, Kagoshima

891-0133

Local Institution, Kagoshima

920-8616

Local Institution, Kanazawa

309-1793

Local Institution, Kasama

673-1462

Local Institution, Katō

800-0031

Local Institution, Kitakyushu

800-0296

Local Institution, Kitakyushu

807-8556

Local Institution, Kitakyushu

364-8501

Local Institution, Kitamoto

650-0017

Local institution, Kobe

654-0047

Local institution, Kobe

781-0112

Local Institution, Kochi

861-1196

Local Institution, Kōshi

862-0976

Local institution, Kumamoto

390-8601

Local Institution, Matsumoto

380-8582

Local Institution, Nagano

940-2085

Local Institution, Nagaoka

850-0832

Local Institution, Nagasaki

460-0001

Local Institution, Nagoya

466-8560

Local Institution, Nagoya

275-0006

Local Institution, Narashino

286-0041

Local Institution, Narita

700-8607

Local Institution, Okayama

545-8585

Local institution, Osaka

198-0042

Local institution, Ōme

989-6183

Local Institution, Ōsaki

001-0907

Local institution, Sapporo

060-0001

Local Institution, Sapporo

060-8648

Local Institution, Sapporo

063-0811

Local Institution, Sapporo

857-1195

Local Institution, Sasebo

350-1305

Local Institution, Sayama

980-6116

Local Institution, Sendai

982-0032

Local Institution, Sendai

983-8512

Local Institution, Sendai

420-0821

Local Institution, Shizuoka

933-0874

Local Institution, Takaoka

370-0053

Local Institution, Takasaki

101-0062

Local institution, Tokyo

104-8560

Local Institution, Tokyo

130-8575

Local Institution, Tokyo

160-8582

Local Institution, Tokyo

162-8543

Local Institution, Tokyo

162-8655

Local Institution, Tokyo

170-8476

Local Institution, Tokyo

173-8610

Local Institution, Tokyo

174-0071

Local Institution, Tokyo

179-0072

Local Institution, Tokyo

053-0018

Local Institution, Tomakomai

930-0138

Local Institution, Toyama

930-0194

Local Institution, Toyama

321-0964

Local Institution, Utsunomiya

231-8682

Local institution, Yokohama

236-0004

Local institution, Yokohama

284-0003

Local Institution, Yotsukaidō

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT01758198 - Abatacept Post-marketing Clinical Study in Japan | Biotech Hunter | Biotech Hunter